Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Legendre

Showing results (291-300 of 309) with videos related to

Pageof 31
Sort By:
Journal of Transplantation|May 16, 2014
Three-year outcomes in kidney transplant patients randomized to steroid-free immunosuppression or steroid withdrawal, with enteric-coated mycophenolate sodium and cyclosporine: the infinity studyA Thierry, G Mourad, M Büchler, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2016
Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 GenotypeN Pallet, I Etienne, M Buchler, et al.
Journal of Medical Virology|June 29, 2004
Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infectionS Alain, S Hantz, C Scieux, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 14, 2014
Recurrent 2,8-dihydroxyadenine nephropathy: a rare but preventable cause of renal allograft failureM Zaidan, R Palsson, E Merieau, et al.
Transplantation|May 26, 1999
Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF)D Farge, C Lebbé, Z Marjanovic, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 9, 2016
Estimated or Measured GFR in Living Kidney Donors Work-up?F Gaillard, M Flamant, S Lemoine, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 19, 2016
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized StudyP Gatault, N Kamar, M Büchler, et al.
Trials|June 23, 2019
PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled studyE Gaiffe, T Crepin, J Bamoulid, et al.
Transplantation Proceedings|November 23, 2006
Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipientsL Rostaing, G Mourad, N Kamar, et al.
Transplantation Proceedings|September 15, 2012
Living donor psychosocial assesment/follow-up practices in the partners' countries of the ELIPSY projectM Manyalich, A Menjívar, L Yucetin, et al.
Pageof 31

Showing results (291-300 of 309) with videos related to

Sort By:
Pageof 31
Journal of Transplantation|May 16, 2014
Three-year outcomes in kidney transplant patients randomized to steroid-free immunosuppression or steroid withdrawal, with enteric-coated mycophenolate sodium and cyclosporine: the infinity studyA Thierry, G Mourad, M Büchler, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2016
Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 GenotypeN Pallet, I Etienne, M Buchler, et al.
Journal of Medical Virology|June 29, 2004
Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infectionS Alain, S Hantz, C Scieux, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 14, 2014
Recurrent 2,8-dihydroxyadenine nephropathy: a rare but preventable cause of renal allograft failureM Zaidan, R Palsson, E Merieau, et al.
Transplantation|May 26, 1999
Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF)D Farge, C Lebbé, Z Marjanovic, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 9, 2016
Estimated or Measured GFR in Living Kidney Donors Work-up?F Gaillard, M Flamant, S Lemoine, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 19, 2016
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized StudyP Gatault, N Kamar, M Büchler, et al.
Trials|June 23, 2019
PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled studyE Gaiffe, T Crepin, J Bamoulid, et al.
Transplantation Proceedings|November 23, 2006
Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipientsL Rostaing, G Mourad, N Kamar, et al.
Transplantation Proceedings|September 15, 2012
Living donor psychosocial assesment/follow-up practices in the partners' countries of the ELIPSY projectM Manyalich, A Menjívar, L Yucetin, et al.
Pageof 31